Incannex Healthcare Inc Quick Ratio (IXHL) starting from the fourth quarter 2026 to fourth quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Incannex Healthcare Inc  (NASDAQ: IXHL)

Incannex Healthcare Inc's Quick Ratio

IXHL's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2026, Quick Ratio fell to 4.25 below Incannex Healthcare Inc average.

Within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Quick Ratio than Incannex Healthcare Inc in fourth quarter 2026. While Quick Ratio total ranking in the fourth quarter 2026 has deteriorated compared to the prior quarter from 10 to 56.

Explain Quick Ratio?
How much Cash & cash equivalents IXHL´s has?
What are IXHL´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IXHL Quick Ratio (Jun 30 2026)
Q4		 (Mar 31 2026)
Q3		 (Dec 31 2025)
Q2		 (Sep 30 2025)
2025		 (Jun 30 2025)
Q4
Y / Y Current Liabilities Change -14.25 % -73.85 % -73.51 % 21.57 % -1.14 %
Y / Y Cash & cash equivalent Change 350.24 % 1009.37 % 3184.08 % 1920.4 % 156.73 %
Quick Ratio MRQ 4.25 38.64 44.54 5.45 0.81
IXHL's Total Ranking # 56 # 10 # 55 # #
Seq. Current Liabilities Change 727.19 % 24.56 % -88.49 % -27.71 % 152.31 %
Seq. Cash & cash equivalent Change -9.05 % 8.06 % -5.98 % 387.27 % 124.09 %



Quick Ratio fourth quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 9
Overall Market # 56


Quick Ratio Statistics
High Average Low
44.54 15.35 0.36
(Dec 31 2025)   (Dec 31 2024)




Financial Statements
Incannex Healthcare Inc's Current Liabilities $ 16 Millions Visit IXHL's Balance sheet
Incannex Healthcare Inc's Cash & cash equivalent $ 68 Millions Visit IXHL's Balance sheet
Source of IXHL's Sales Visit IXHL's Sales by Geography


Cumulative Incannex Healthcare Inc's Quick Ratio

IXHL's Quick Ratio for the trailling 12 Months

IXHL Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -23.34 % -17.57 % -18.47 % -22.62 % -23.86 %
Y / Y Cash & cash equivalent TTM Growth 934.91 % 1166.37 % 684.8 % 45.6 % -76.83 %
Quick Ratio TTM 8.66 6.53 4 2.15 0.64
Total Ranking TTM # 149 # 409 # 1040 # 1031 # 1062
Seq. Current Liabilities TTM Growth -7.46 % -13.29 % -9.49 % 5.56 % -0.5 %
Seq. Cash & cash equivalent TTM Growth 22.74 % 41.32 % 68.78 % 253.51 % 50.19 %

Quick ratio ranking by company, industry and sector >> Back to IXHL Financial Strength Comparisons >> Go to Compare IXHL Quick Ratio to its Competitors

On the trailing twelve months basis IXHL Cash & cash equivalent more than doubled by 350.24 % in Q4 2026 year on year, while Current Liabilities more than doubled to $16 millions, this led to increase in in Incannex Healthcare Inc's Quick Ratio to 8.66, above IXHL average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 414 other companies have achieved higher Quick Ratio than Incannex Healthcare Inc. While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending third quarter 2026 at 2574.

Explain Quick Ratio?
How much Cash & cash equivalents IXHL´s has?
What are IXHL´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 415
Healthcare Sector # 845
Within the Market # 56


trailing twelve months Quick Ratio Statistics
High Average Low
9.26 3.12 1.11
(Mar 31 2026)   (Mar 31 2025)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Aardvark Therapeutics Inc   11.57 $ 73.921  Millions$ 6.387  Millions
Dyne Therapeutics Inc   11.51 $ 898.475  Millions$ 78.029  Millions
Evommune Inc   11.50 $ 201.014  Millions$ 17.487  Millions
Bicara Therapeutics Inc   11.44 $ 497.259  Millions$ 43.475  Millions
Lipocine Inc   11.25 $ 23.267  Millions$ 2.068  Millions
Xenon Pharmaceuticals Inc   10.85 $ 930.686  Millions$ 85.795  Millions
Bicycle Therapeutics Plc  10.71 $ 510.052  Millions$ 47.635  Millions
Entrada Therapeutics Inc   10.44 $ 223.112  Millions$ 21.371  Millions
Vera Therapeutics Inc   10.33 $ 499.161  Millions$ 48.321  Millions
Ideaya Biosciences Inc   10.03 $ 828.955  Millions$ 82.677  Millions
Gri Bio Inc   9.95 $ 10.947  Millions$ 1.100  Millions
Renovorx Inc   9.86 $ 18.579  Millions$ 1.884  Millions
Savara Inc   9.83 $ 173.034  Millions$ 17.599  Millions
Bullfrog Ai Holdings Inc   9.79 $ 6.918  Millions$ 0.707  Millions
Enveric Biosciences Inc   9.63 $ 8.296  Millions$ 0.861  Millions
Pliant Therapeutics Inc   9.62 $ 158.500  Millions$ 16.484  Millions
Rezolute Inc   9.44 $ 107.801  Millions$ 11.418  Millions
Crescent Biopharma Inc   9.26 $ 171.593  Millions$ 18.537  Millions
Marker Therapeutics inc   9.10 $ 22.031  Millions$ 2.420  Millions
Synlogic Inc   9.03 $ 13.200  Millions$ 1.461  Millions
Spruce Biosciences Inc   8.78 $ 96.300  Millions$ 10.963  Millions
Newamsterdam Pharma Company N v   8.69 $ 633.854  Millions$ 72.974  Millions
Medicinova Inc   8.58 $ 25.416  Millions$ 2.961  Millions
Lixte Biotechnology Holdings Inc   8.45 $ 12.670  Millions$ 1.500  Millions
Atrium Therapeutics Inc   8.38 $ 264.135  Millions$ 31.508  Millions
Cytomx Therapeutics Inc   8.29 $ 330.280  Millions$ 39.861  Millions
Grace Therapeutics Inc  8.24 $ 13.756  Millions$ 1.669  Millions
Talphera Inc   7.98 $ 33.410  Millions$ 4.188  Millions
Rocket Pharmaceuticals Inc   7.79 $ 342.940  Millions$ 44.031  Millions
Milestone Pharmaceuticals Inc   7.73 $ 171.481  Millions$ 22.184  Millions

Date modified: 2026-09-26T02:53:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.